Kraig Biocraft Laboratories, Inc. Succeeds in Attaining Higher Levels of Transient...

Kraig Biocraft Laboratories, Inc. Succeeds in Attaining Higher Levels of
Transient Expression of Targeted DNA

LANSING, Mich., March 30, 2009 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories,
Inc. (OTCBB:KBLB) is very pleased to report that scientists working in the
Company's sponsored research program at the University of Notre Dame have
succeeded in significantly increasing the number and proportion of DNA
insertions which yield transient expression of the Company's targeted marker
protein. "These results, which are occurring in the latest generation of genetic
insertions performed in the laboratory, are very exciting, and we believe that
it is further evidence that the research team is on the right track," said CEO
Kim K. Thompson.

The increase which the team is reporting is in both absolute numbers and in the
percentage of insertions which ultimately result in the expression. This
progress report from the laboratory follows the Company's announcement of the
achievement of a number of milestones over the last six months. "This is the
first time we have seen the number of DNA insertions yielding transient
expression reach the triple digits. We do seem to be in a state of acceleration
in terms of the pace of laboratory achievement," added Mr. Thompson. For more
information on Kraig Biocraft Laboratories, please visit the Company's web site:
www.KraigLabs.com

The Kraig Biocraft Laboratories, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=4817

Statements in this press release about the company's future and expectations
other than historical facts are "forward-looking statements." These statements
are made on the basis of management's current views and assumptions. As a
result, there can be no assurance that management's expectations will
necessarily come to pass. These forward-looking statements generally can be
identified by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops", "researching," "research," "potential," "could"
or other words or phrases of similar import. Similarly, statements in this
release that describe the Company's business strategy, outlook, objectives,
plans, intentions or goals should all be considered forward-looking statements.
All such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from those in
forward-looking statements. Management cautions that its ability to further its
research, and create commercially viable products may be affected by the
competitive environment, the Company's financial condition and its ability to
raise sufficient capital to meet the financial obligations of its business plan
and to fund its continuing operations.

-0-
CONTACT: Kraig Biocraft Laboratories, Inc.
Kim K. Thompson, CEO
(517) 336-0807
info@KraigLabs.com